MTCM
NUCLW

Mint Tower Capital Management’s Eagle Nuclear Energy Corp Warrants NUCLW Stock Holding History

Mint Tower Capital Management’s Portfolio NUCLW Stock Details NUCLW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$77K Buy
+10,000
New +$12.9K 0.01% 268

Other funds holding NUCLW

LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
ACM
Arosa Capital Management Miami Beach, Florida $660M AUM 210.26% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Mint Tower Capital Management's NUCLW Position: Q1 2026 in Review

Mint Tower Capital Management opened a new position in Eagle Nuclear Energy Corp Warrants (NUCLW) in Q1 2026: 10,000 shares worth $77K. The stake represents 0.01% of the portfolio and ranks #268 among its holdings.

26 funds tracked by Wall St. Rank hold NUCLW as of Q1 2026.

  • Mint Tower Capital Management held 10,000 shares of Eagle Nuclear Energy Corp Warrants worth $77K as of Q1 2026.
  • Eagle Nuclear Energy Corp Warrants was a new Mint Tower Capital Management position in Q1 2026.
  • Eagle Nuclear Energy Corp Warrants made up 0.01% of Mint Tower Capital Management's portfolio in Q1 2026, its #268 holding.
  • 26 funds tracked by Wall St. Rank held Eagle Nuclear Energy Corp Warrants as of Q1 2026.

Based on Mint Tower Capital Management's 13F filing for Q1 2026, filed 4 May 2026.